ALGIPRO - Alginates by Production Scale Fermentation and Epimerisation

该项目名为ALGIPRO，是挪威和英国之间的创新合作努力。它将把20多年的学术研究转化为海藻酸盐的工业规模生产过程。工艺创新中心有限公司(英国)在SINTEF(挪威)开发的基础上带头扩大规模。AlgiPharma AS(挪威)将使用该产品作为其治疗囊性纤维化、慢性阻塞性肺病和慢性创面药物的活性药物成分。FMC生物聚合物(英国、挪威)将在食品和药品市场的现有和新应用中销售该产品。如果成功，ALGIPRO将促进向市场推出新的医药产品，从而减轻患者的痛苦，并可能降低医疗成本。此外，它还将成为对抗多重耐药细菌的新工具。

The project, ALGIPRO, is an innovative collaborative effort between Norway and the UK. It will translate over 20 years of academic research into an industrial scale production process for alginates. The Centre for Process Innovation Ltd. (UK) is leading the scale-up based on development by SINTEF (Norway). AlgiPharma AS (Norway) will use the product as the Active Pharmaceutical Ingredient in its development of medicines for cystic fibrosis, COPD and chronic wounds. FMC Biopolymer (UK, Norway) will market the product in existing and new applications within the food and pharmaceutical markets.If successful ALGIPRO will facilitate the introduction of novel medicinal products to the market that will ease patient suffering and potentially reduce healthcare costs. In addition it will be a new tool in fighting multi-drug resistant bacteria.